skip to main content
Idioma:
Refinado por: assunto: Adult remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

Dieci, M.V. ; Prat, A. ; Tagliafico, E. ; Paré, L. ; Ficarra, G. ; Bisagni, G. ; Piacentini, F. ; Generali, D.G. ; Conte, P. ; Guarneri, V.

Annals of oncology, 2016-10, Vol.27 (10), p.1867-1873 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey
Material Type:
Artigo 		Adicionar ao Meu Espaço

Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey

Banerjee, S. ; Califano, R. ; Corral, J. ; de Azambuja, E. ; De Mattos-Arruda, L. ; Guarneri, V. ; Hutka, M. ; Jordan, K. ; Martinelli, E. ; Mountzios, G. ; Ozturk, M.A. ; Petrova, M. ; Postel-Vinay, S. ; Preusser, M. ; Qvortrup, C. ; Volkov, M.N.M. ; Tabernero, J. ; Olmos, D. ; Strijbos, M.H.

Annals of oncology, 2017-07, Vol.28 (7), p.1590-1596 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M.V. ; Conte, P. ; Bisagni, G. ; Brandes, A.A. ; Frassoldati, A. ; Cavanna, L. ; Musolino, A. ; Giotta, F. ; Rimanti, A. ; Garrone, O. ; Bertone, E. ; Cagossi, K. ; Sarti, S. ; Ferro, A. ; Piacentini, F. ; Maiorana, A. ; Orvieto, E. ; Sanders, M. ; Miglietta, F. ; Balduzzi, S. ; D’Amico, R. ; Guarneri, V.

Annals of oncology, 2019-03, Vol.30 (3), p.418-423 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

Berardi, R. ; Torniai, M. ; Cona, M.S. ; Cecere, F.L. ; Chiari, R. ; Guarneri, V. ; La Verde, N. ; Locati, L. ; Lorusso, D. ; Martinelli, E. ; Giannarelli, D. ; Garassino, M.C.

ESMO open, 2021-04, Vol.6 (2), p.100053-100053, Article 100053 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Conte, P. ; Frassoldati, A. ; Bisagni, G. ; Brandes, A.A. ; Donadio, M. ; Garrone, O. ; Piacentini, F. ; Cavanna, L. ; Giotta, F. ; Aieta, M. ; Gebbia, V. ; Molino, A. ; Musolino, A. ; Ferro, A. ; Maltoni, R. ; Danese, S. ; Zamagni, C. ; Rimanti, A. ; Cagossi, K. ; Russo, A. ; Pronzato, P. ; Giovanardi, F. ; Moretti, G. ; Lombardo, L. ; Schirone, A. ; Beano, A. ; Amaducci, L. ; Bajardi, E.A. ; Vicini, R. ; Balduzzi, S. ; D’Amico, R. ; Guarneri, V.

Annals of oncology, 2018-12, Vol.29 (12), p.2328-2333 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study

Bosio, A. ; Cerretti, G. ; Padovan, M. ; Caccese, M. ; Denaro, L. ; Chioffi, F. ; Della Puppa, A. ; Aldegheri, V. ; Guarneri, V. ; Zagonel, V. ; Lombardi, G.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-05, Vol.35 (5), p.e319-e327 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

Marinovich, Michael L ; Macaskill, Petra ; Irwig, Les ; Sardanelli, Francesco ; Mamounas, Eleftherios ; von Minckwitz, Gunter ; Guarneri, Valentina ; Partridge, Savannah C ; Wright, Frances C ; Choi, Jae Hyuck ; Bhattacharyya, Madhumita ; Martincich, Laura ; Yeh, Eren ; Londero, Viviana ; Houssami, Nehmat

BMC cancer, 2015-10, Vol.15 (1), p.662-662, Article 662 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study

CONTE, P. F ; DONATI, S ; NACCARATO, A. G ; ESPOSTI, R. Degli ; BONARDI, S ; BOTTINI, A ; SARACCHINI, S ; TUMOLO, S ; GULLO, G ; SANTORO, A ; CRINO, L ; GENNARI, A ; GUARNERI, V ; ORLANDINI, C ; RONDINI, M ; RONCELLA, M ; MARINI, L ; COLLECCHI, P ; VIACAVA, P

British journal of cancer, 2005-08, Vol.93 (4), p.406-411 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

Boccardo, Francesco ; Pace, Maurizio ; Guarneri, Domenico ; Canobbio, Luciano ; Curotto, Antonio ; Martorana, Giuseppe

Cancer, 1994-04, Vol.73 (7), p.1932-1936 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
10
Phase II study of navelbine in advanced renal cell carcinoma
Phase II study of navelbine in advanced renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of navelbine in advanced renal cell carcinoma

Canobbio, Luciano ; Boccardo, Francesco ; Guarneri, Domenico ; Calabria, Caterina ; Decensi, Andrea ; Curotto, Antonio ; Martorana, Guiseppe ; Giuliani, Luciano

European journal of cancer & clinical oncology, 1991-01, Vol.27 (6), p.804-805 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1989  (2)
  2. 1989Até1993  (2)
  3. 1994Até2014  (2)
  4. 2015Até2017  (3)
  5. Após 2017  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.